When.com Web Search

  1. Ads

    related to: zolgensma gene therapy nejm clinic bloomington wi jobs openings

Search results

  1. Results From The WOW.Com Content Network
  2. Onasemnogene abeparvovec - Wikipedia

    en.wikipedia.org/wiki/Onasemnogene_abeparvovec

    KEGG. D11559. Onasemnogene abeparvovec, sold under the brand name Zolgensma, is a gene therapy used to treat spinal muscular atrophy (SMA), [6][7] a disease causing muscle function loss in children. It involves a one-time infusion of the medication into a vein. [6] It works by providing a new copy of the SMN gene that produces the SMN protein.

  3. Betibeglogene autotemcel - Wikipedia

    en.wikipedia.org/wiki/Betibeglogene_autotemcel

    Betibeglogene autotemcel, sold under the brand name Zynteglo, is a gene therapy for the treatment for beta thalassemia. [1][5][2] It was developed by Bluebird Bio and was given breakthrough therapy designation by the US Food and Drug Administration in February 2015. [6][7] The most common adverse reactions include reduced platelet and other ...

  4. Novartis Gene Therapies - Wikipedia

    en.wikipedia.org/wiki/Novartis_Gene_Therapies

    Novartis Gene Therapies, until 2020 known as AveXis, is a biotechnology company that develops treatments for rare neurological genetic disorders. It was founded in Dallas , Texas , United States in 2012 by John Carbona after reorganizing a company called BioLife Cell Bank founded by David Genecov and John Harkey.

  5. Exagamglogene autotemcel - Wikipedia

    en.wikipedia.org/wiki/Exagamglogene_autotemcel

    The therapy has a US list price of US$2.2 million. [16] The cost effectiveness threshold of the therapy in the US is estimated to be between $1.35 million and $2.05 million [ 17 ] depending on perspective (healthcare vs limited societal) and assuming the willingness to pay for 1 quality-adjusted life year (QALY) at $100,000–$150,000.

  6. Gene therapy - Wikipedia

    en.wikipedia.org/wiki/Gene_therapy

    The modified gene therapy strategy of antisense IGF-I RNA (NIH n˚ 1602) [162] using antisense / triple helix anti-IGF-I approach was registered in 2002, by Wiley gene therapy clinical trial - n˚ 635 and 636.

  7. Virotherapy - Wikipedia

    en.wikipedia.org/wiki/Virotherapy

    Virotherapy. Virotherapy is a treatment using biotechnology to convert viruses into therapeutic agents by reprogramming viruses to treat diseases. There are three main branches of virotherapy: anti-cancer oncolytic viruses, viral vectors for gene therapy and viral immunotherapy. These branches use three different types of treatment methods ...

  1. Ad

    related to: zolgensma gene therapy nejm clinic bloomington wi jobs openings